Dr. Matusov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8723 Alden Dr
Los Angeles, CA 90048Phone+1 310-423-8784Fax+1 310-423-2665
Education & Training
- Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2018 - 2021
- Santa Barbara Cottage HospitalResidency, Internal Medicine, 2015 - 2018
Certifications & Licensure
- CA State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension Start of enrollment: 2024 Feb 01
- A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2021 Dec 02
Publications & Presentations
PubMed
- 274 citationsDevelopment of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.Tanayott Thaweethai, Sarah E Jolley, Elizabeth W Karlson, Emily B Levitan, Bruce Levy
JAMA. 2023-06-13 - 117 citationsPre-existing traits associated with Covid-19 illness severity.Joseph E. Ebinger, Natalie Achamallah, Hongwei Ji, Brian Claggett, Nancy Sun
Plos One. 2020-05-10 - 46 citationsResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial., Jens D Lundgren, Birgit Grund, Christina E Barkauskas, Thomas L Holland
Annals of Internal Medicine. 2022-02-01
Professional Memberships
- Member
- Member
- Member
- Pulmonary Hypertension AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: